(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 90.74% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.26%.
Ideaya Biosciences's revenue in 2024 is $11,960,000.On average, 6 Wall Street analysts forecast IDYA's revenue for 2024 to be $1,337,595,495, with the lowest IDYA revenue forecast at $591,370,458, and the highest IDYA revenue forecast at $2,112,037,350. On average, 4 Wall Street analysts forecast IDYA's revenue for 2025 to be $2,747,338,185, with the lowest IDYA revenue forecast at $1,689,629,880, and the highest IDYA revenue forecast at $5,464,263,032.
In 2026, IDYA is forecast to generate $7,360,957,054 in revenue, with the lowest revenue forecast at $780,609,005 and the highest revenue forecast at $21,296,095,008.